Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma.

MLA

Kamper, Peter, et al. “Proteomic Analysis Identifies Galectin-1 as a Predictive Biomarker for Relapsed/Refractory Disease in Classical Hodgkin Lymphoma.” Blood, vol. 117, no. 24, June 2011, pp. 6638–49. EBSCOhost, https://doi.org/10.1182/blood-2010-12-327346.

APA

Kamper, P., Ludvigsen, M., Bendix, K., Hamilton-Dutoit, S., Rabinovich, G. A., Møller, M. B., Nyengaard, J. R., Honoré, B., & d’Amore, F. (2011). Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma. Blood, 117(24), 6638–6649. https://doi.org/10.1182/blood-2010-12-327346

Chicago

Kamper, Peter, Maja Ludvigsen, Knud Bendix, Stephen Hamilton-Dutoit, Gabriel A. Rabinovich, Michael Boe Møller, Jens R. Nyengaard, Bent Honoré, and Francesco d’Amore. 2011. “Proteomic Analysis Identifies Galectin-1 as a Predictive Biomarker for Relapsed/Refractory Disease in Classical Hodgkin Lymphoma.” Blood 117 (24): 6638–49. doi:10.1182/blood-2010-12-327346.